Medical Injustice: Trans-Pacific Partnership Enriches Big Pharma at Cost Of People’s Health

Through "evergreening,” pharmaceutical companies could could retain ownership of and royalties to drugs for which their patents have expired – limiting access to generic forms of medicine that millions need.

// Read More